MedAlliance acquired by Cordis for $1.13 billion

Swiss-based medical technology company MedAlliance has announced acquisition by Cordis for $1.13 billion. Cordis will play a pivotal role in the marketing, distribution, and global accessibility of MedAlliance's revolutionary Drug-Eluting Balloon, the company said in a statement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Iglricq
via IFTTT